Table 2.

Characteristics of the reported cases.

	Case I	Case II	Case III	Case IV	Case V	Case VI	Case VII
Age (years)	70	48	57	74	64	66	67
Sex	M	F	M	M	M	M	M
Past medical history/comorbidities	DM2, HTN, MM	DM2, HTN	DM2	None	None	DM2, HTN, CAD, CKD	DM2, HTN, CAD, CKD, OSA
COVID-19 symptoms	Fever, dry cough, SOB, with myalgia	Fever, cough with sputum, generalized body ache, diffuse abdominal pain, running nose, and SOB	Fever and SOB	Fever, SOB, tongue pain/ulceration, and dry cough	Cough, SOB, fever	Fever and runny nose	SOB
Supplemental oxygen	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Mechanical ventilation	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Delay between COVID-19 onset and neurological symptoms (days)	31	13	46	54	40	25	26
Neurological symptoms	Low GCS	Low GCS	Low GCS	Low GCS	Low GCS	Low GCS	Low GCS
Cellularity, cells/mm3	1	N/A	N/A	1	N/A	N/A	N/A
Protein levels, g/L	0.3	N/A	N/A	0.47	N/A	N/A	N/A
SARS-CoV-2 RT-PCR assay	Positive	Positive	Positive	Positive	Positive	Positive	Positive
Encephalopathy classification	Probable	Probable	Possible	Possible	Possible	Possible	Possible

Abbreviations: M: male; F: female; DM2: diabetes mellitus type 2; HTN: hypertension; MM: multiple myeloma; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; RT-PCR: reverse transcription-polymerase chain reaction; COVID-19: coronavirus disease 2019; GCS: Glasgow Coma Scale; CAD: coronary artery disease; CKD: chronic kidney disease; OSA: obstructive sleep apnea; SOB: shortness of breath; N/A: not available.